The European LeukemiaNet

220 Participating Centers in 44 Countries with more than 1000 researchers and clinicians are cooperating in the European LeukemiaNet. The objective is to integrate the about 120 leading leukemia trial groups (CML, AML, ALL, CLL, MDS, MPN), their interdisciplinary partner groups (diagnostics, treatment research, registry, guidelines), industry and SMEs across Europe to form a network promoting cooperative research for curing leukemia.

Virtual Meeting, 9.3.2021
Virtual ELN WP Sessions
Virtual ELN WP Sessions

Program:
WP10 (flow cytometry)
WP4 (CML/HARMONY PLUS)
HARMONY
WP9 (MPN)
WP8 (MDS/MDS-RIGHT)
WP14 (Transplantation/GvHD)

The next annual ELN symposium (physical) is planned in Mannheim on September 7, 2021, Corona permitting, alternative March 14, 2022

The next ELN Breakfast Meeting is planned in Atlanta on December 12, 2021, at 6 AM.

Videos
Mannheim, 7.9.2021
20. ELN / 17. KNL Symposium 7.9.2021
20. ELN / 17. KNL Symposium 7.9.2021

The next ELN-Symposium is planned for September 7, 2021, in Mannheim, Rosengarten Convention Center, Corona permitting.

Registration with eva.lehrke@text-event.de

Atlanta 12.12.2021
ELN Breakfast Meeting
ELN Breakfast Meeting

ELN plans for another Breakfast Meeting in Atlanta at ASH on 12.12.2021, 6 AM as usual, Corona permitting

Network info and goals

220 Participating Centers in 44 Countries with more than 1000 researchers and clinicians are cooperating in the European LeukemiaNet. The objective is to integrate the about 120 leading leukemia trial groups (CML, AML, ALL, CLL, MDS, MPN), their interdisciplinary partner groups (diagnostics, treatment research, registry, guidelines), industry and SMEs across Europe to form a network promoting cooperative research for curing leukemia.

Achievements of the ELN

Achievements in addition to the integration of leukemia research among its more than 1000 physicians and researchers and 220 institutions are the more than 100 management recommendations and guidelines for all forms of leukemia and related interdisciplinary specialities. A selection of the recommendations 2016-2018 is included in the attachment. We also list a selection of publications by others which carry the European LeukemiaNet in their titles. The key instrument of integration are regular meetings, in particular the annual ELN symposium  at no cost for participants

Definition and funding of the European LeukemiaNet

The European LeukemiaNet is a publicly funded research network of excellence. Goal is cure of leukemia by integration of European leukemia research and spread of excellence. The website delivers information for physicians, researchers and the public on the disease, ongoing clinical trials, research projects and organizational matters. You can get information about the European LeukemiaNet in various European languages. The European LeukemiaNet was funded by the 6th Framework Program of the European Community until 2011, by the European Research Foundation until 2015 and is currently funded by the ELN-Foundation.

Achievements ELN 2016-2018

ELN Steering Committee (ELN SC)

ELN SC members

  • Jane Apperley
  • Michele Baccarani
  • Tiziana Barbui
  • Gianni Barosi
  • Renato Bassan
  • Marie C. Bené
  • Lars Bullinger
  • Hartmut Döhner
  • Hervé Dombret
  • Martin Dugas
  • Hermann Einsele
  • Pierre Fenaux
  • Robin Foa
  • Paolo Ghia
  • Nicola Gökbuget 
  • Francois Guilhot
  • Detlef Haase
  • Claudia Haferlach
  • Torsten Haferlach
  • Michael Hallek
  • Jörg Hasford
  • Eva Hellström-Lindberg
  • Jesus Hernandez
  • Andreas Hochhaus
  • Dieter Hoelzer
  • Jean-Jacques Kiladjian
  • Hans-Jochem Kolb
  • Per Ljungman
  • Francois-Xavier Mahon 
  • Emili Montserrat
  • Carsten Müller-Tidow
  • Dietger Niederwieser
  • Gert Ossenkoppele
  • Heike Pahl
  • Josep Ribera
  • Harald Rieder
  • Giuseppe Saglio
  • Miguel Sanz
  • Hubert Serve
  • Leif Stenke
  • Christian Thiede
  • Theo de Witte
  • Gina Zini
ELN-Coordinator
  • Rüdiger Hehlmann